Abiomed (NASDAQ:ABMD) reported earnings of $0.80 per share beating Walls Streets expectations.

ME Staff
-
0

Abiomed (NASDAQ:ABMD) reported Q4 2018 earnings this Morning, coming in at $0.80 per share, beating Wall Street’s estimates of $0.56 per Share. Revenue for the quarter came in at $174.44 million beating analyst estimates of $164.30 million

Recent Insider Trading for Abiomed (NASDAQ:ABMD)

  • On 2/20/2018 Andrew J Greenfield, VP, sold 20,000 with an average share price of $270.36 per share and the total transaction amounting to $5,407,200.00.
  • On 10/30/2017 Dorothy E Puhy, Director, sold 6,364 with an average share price of $179.08 per share and the total transaction amounting to $1,139,665.12.
  • On 10/30/2017 Michael G Howley, VP, sold 10,000 with an average share price of $178.64 per share and the total transaction amounting to $1,786,400.00.
  • On 10/2/2017 Andrew J Greenfield, VP, sold 11,282 with an average share price of $169.32 per share and the total transaction amounting to $1,910,268.24.
  • On 8/30/2017 Eric A Md Rose, Director, sold 982 with an average share price of $145.17 per share and the total transaction amounting to $142,556.94.
  • On 8/24/2017 Eric A Md Rose, Director, sold 23,018 with an average share price of $151.09 per share and the total transaction amounting to $3,477,789.62.



Dividend History for Abiomed (NASDAQ:ABMD)



    Recent Trading for Abiomed (NASDAQ:ABMD)
    Shares of Abiomed closed the previous trading session at 333.28 up +31.14 10.31% with 338.69000244140625 shares trading hands.